Evolus Stock

Evolus P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Evolus (EOLS) as of Aug 13, 2026 is -6.59. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -15.49 — a change of -57.41% (higher).

P/CF

-6.59

YoY

-57.41%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Evolus is 2026 -6.59 . P/CF (Price-to-Cash-Flow Ratio) of Evolus was 2025 -15.49 . It decreases by -57.41% higher compared to the previous year.
Access this data via the Eulerpool API

Evolus Stock analysis

What does Evolus do? Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolus stock

P/CF (Price-to-Cash-Flow Ratio) of Evolus is -6.59 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of Evolus changed from -15.49 to -6.59, representing a -57.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Evolus since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Evolus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Evolus

All Key Metrics — Evolus